Agenda for Day 3 - Thursday August 13th, 2026 - EST/EDT (Eastern Daylight, GMT-4)
An exclusive forum for senior compliance, transparency and HCP engagement leaders to discuss shared challenges, emerging pressures, and the evolving role of the function across the industry.
- Segment 1: Leadership Perspectives & Industry Priorities – Discuss top-of-mind issues such as global reporting complexities, AI adoption, and evolving enforcement trends
- Segment 2: Executive Dialogue to Navigate Emerging Pressures – Explore strategies for balancing innovaton with compliance, managing risk during organizational change, and preparing for heightened scrutiny
- Segment 3: Collaborative Case Discussions – Work through real-world scenarios on aggregate spend audits, cross-border transfers, and system integration challenges
*This summit is an exclusive, senior-level benchmarking discussion. Attendees should have a minimum of 5 years’ experience in compliance and transparency and be currently employed at a bio/pharmaceutical or medical device manufacturer. Informa Connect reserves the right to qualify participants for this Summit. To reserve your seat, please email nhu.tran@informa.com.
- Melissa Ince - Director of Global Transparency Reporting, Abbott Laboratories
- Peter Christopulos - Senior Director, Global Transparency Reporting, Johnson & Johnson
Interactive, small-group sessions designed for practical discussions, idea-sharing and collaborative problem-solving. The solution circles are designed to help participants apply learning from the conference and address any outstanding gaps.
- Segment 1: Operational Challenges – Rotate through topic-focused circles on issues like:
- Managing speaker program documentation and FMV justification
- Streamlining aggregate spend data collection and validation
- Coordinating cross-functional workflows for HCP engagement approvals
- Segment 2: Risk Scenarios – Work through realistic cases such as:
- Detecting red flags in HCP contracting or advisory board engagements
- Identifying gaps in Open Payments reporting before audits
- Responding to compliance breaches during global transfers of value
- Andrea Jenner - Transparency Reporting Manager, CSL Seqirus
- Michael Ade - Manager, US Transparency Data Operations & Reporting, GSK
- Panelists from key partner functions, including finance, IT, data governance, and commercial operations, share how they work with transparency and HCP engagement teams to resolve challenges and improve operational efficiency
- Learn where collaboration breaks down, how to avoid common pitfalls, and what practical steps teams can take to strengthen communication and alignment
- Leave with best practices for building durable partnerships that support compliance accuracy. Reduce risk, and improve business readiness
- Sara Merin - Senior Assistant General Counsel, US Office of Ethics & Compliance, Bayer
- Itzy Wallace - Global Senior Director, Head of Compliance & Risk, Mayne Pharma
- Jessica Constant - Associate Director - Compliance & Business Controls, AstraZeneca
- Hear firsthand experiences navigating recent CMS audits, including what surprised them, what worked well, and what they would approach differently next time
- Explore practical insights into documentation readiness, data quality expectations, business partner coordination, and how to prepare teams for requests, follow-ups, and timelines
- Gain actionable takeaways for strengthening internal controls, streamlining audit preparation, and building a more confident, resilient reporting function, regardless of company size or resources
- Jonathan Wozniak - Head of Global Transparency Reporting, Daiichi Sankyo
- Brian Bohnenkamp - Partner, FDA & Life Sciences, King & Spalding
- Examine how new engagement formats, including HCP social media influencers, digital educators, and advisory boards are creating unfamiliar compliance and reporting considerations in the US market
- Review emerging signals from regulators, industry standards, and enforcement commentary around transparency, promotion, fair market evaluation, and appropriate use of compensation for HCPs engagement through digital channels
- Discuss practical guidance for valuing and documenting these engagements, including criteria for assessing influence, establishing fair market value, clarifying deliverables, and ensuring consistent oversight across non-traditional HCP activities
- Vishal Khapane - Senior Director, External Expert Engagement Services, AstraZeneca
- A fast-paced, forward-looking conversation highlighting the biggest shifts, signals, and opportunities shaping the next era of transparency and HCP engagement
- Hear as industry experts reflect on key theme from the conference and what teams should be preparing for in the years ahead
- Explore where the industry is heading and how organizations can work together to build a more integrated, resilient, and forward-thinking programs
- Karen Lowney - Head of Ethics & Compliance, Sun Pharmaceutical
